申请人:Selwood David
公开号:US20080139493A1
公开(公告)日:2008-06-12
The invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof,
wherein X
1
, X
2
and X
3
are each independently
where Y is an alkylene, alkenylene or alkynylene group, each of which may be optionally substituted with one or more substituents selected from alkyl, halo, CF
3
, OH, alkoxy, NH
2
, CN, NO
2
and COOH; W is absent or is O, S or NH; R
1
, R
2
, R
3
and R
4
are each independently selected from H, alkyl, aryl and a protecting group P
1
;
R
7
, R
8
and R
9
are each independently selected from H, alkyl, halo, CF
3
, OH, alkoxy, NH
2
, CN, NO
2
and COOH; q and r are each independently 1, 2, 3 or 4; q′ and r′ are each independently 0, 1, 2 or 3, where q+q′ and r+r′ each equal 4; p is 1, 2, 3, 4 or 5, and p′ is 0, 1, 2, 3 or 4, where p+p′ is 5; n is 0, 1, 2, 3 . . . 6;
L is (Z)
m
NR
5
R
6
where Z is a hydrocarbyl group and m is 0 or 1;
where R
5
and R
6
are each independently H, CO(CH
2
)
j
Q
1
or C═S(NH)(CH
2
)
k
Q
2
where j and k are each independently 0, 1, 2, 3, 4 or 5, and Q
1
and Q
2
are each independently selected from COOH, a chromophore
or R
5
, R
6
and the nitrogen to which they are attached together form
本发明涉及公式I的化合物或其药学上可接受的盐,其中X1、X2和X3各自独立地为Y的烷基、烯基或炔基基团,其中每个基团可以选择性地被一个或多个取代基选自烷基、卤素、CF3、OH、烷氧基、NH2、CN、NO2和COOH;W不存在或为O、S或NH;R1、R2、R3和R4各自独立地选自H、烷基、芳基和保护基P1;R7、R8和R9各自独立地选自H、烷基、卤素、CF3、OH、烷氧基、NH2、CN、NO2和COOH;q和r各自独立地为1、2、3或4;q'和r'各自独立地为0、1、2或3,其中q+q'和r+r'各自等于4;p为1、2、3、4或5,p'为0、1、2、3或4,其中p+p'等于5;n为0、1、2、3...6;L为(Z)mNR5R6,其中Z为烃基团,m为0或1;其中R5和R6各自独立地为H、CO(CH2)jQ1或C═S(NH)(CH2)kQ2,其中j和k各自独立地为0、1、2、3、4或5,Q1和Q2各自独立地选自COOH、色团或R5、R6和它们所连接的氮共同形成。